KLK3 and prostate carcinoma: Most clinicians, [8–10] learned societies [11,12] and public health committees [13,14], as the US Preventive Service Task Force and the UK National Screening Committee, now agree that the PSA test should not be recommended as screening for prostate cancer in asymptomatic men [15].